[Treatment of psoriasis with etretinate (Tigason)].
D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005050:Etretinate / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy*; D013997:Time Factors; D014467:Ultraviolet Therapy
D005050:Etretinate
Die Behandlung der Psoriasis mit Etretinat (Tigason).